eve Conference Variant Block

Excipient Application for Novel Pharmaceutical Formulation Conference 2006
Excipient Application for Novel Pharmaceutical Formulation Conference 2006
Tue, 08/29/2006  to  Wed, 08/30/2006 ,Shanghai
Novel dosage form development and application accelerate pharmaceutical ingredient industry rapid growth, which requires corresponding regulations to gear to international standards. People pay more and more attention to the increasing business opportunities result from pharmaceutical ingredient and pharmaceutical formulation. [more]

  • Medical & Pharmaceutical

    • 页面

    Package Plan

     

    Registration Fee: USD 660/person

    Includes  luncheons, a welcome dinner and tea breaks etc. 


    eve Conference Detail Testimonial





    Distinguished Guest

    Ms. Yan Zhang

    President, Shanghai MicroPort Medical (Group) Co., Ltd.

    Mr. Fenghua Xia

    CEO, Siemens Shanghai Medical Equipment

    Mr. Fuqing Qian

    CEO, Trauson Medical

    Mr. Weiguo Zhao

    CEO, Beyond Diagnostics Inc.

    Mr. Yu Meng

    President, lifecarenetworks Inc.

    Mr. Shiang Huang

    President, kindstar Global

    Mr. Jie Qin

    President, MedSphere International (Shanghai) Co., Ltd.

    Mr. Hao Wu

    Vice President, Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

    Mr. Jianxin Xu

    GM, Shanghai Upper Bio-Tech Pharma Co.,Ltd

    Dr. Shipeng Song

    Founder, Song's Lab

    SNEAKERS


    eve Conference Contact Block

    Please contact us:

     
    Service Hotline: [800]-820-0083 (Mainland China)  [800]-1122-8811 (International)
    Copyright © Ringier Trade.com. Copyright © Ringier Trade Media Ltd. © 2023.
    All rights reserved. Reproduction in whole or part in any form or medium without express written permission is not allowed.
    Ringier Trade .com © Ringier Trade Media Ltd., accept no responsibility or liability for any information provided by any third party on this website.